As reviewed, we suggest to foundation the payment price for diagnostic radiopharmaceuticals on suggest device Charge data derived from medical center statements. We're not proposing to make use of ASP info for identifying payment rates of non-passthrough diagnostic radiopharmaceuticals with promises info but are trying to get touch upon its use for